Travere Therapeutics Turns a Rare Disease Approval into Two Quarters of Accelerating Sales
The Food and Drug Administration granted Travere Therapeutics full approval for FILSPARI in focal segmental glomerulosclerosis on April 13, 2026, the ...
Last updated: 2026-08-23 05:25:56 ET
The Food and Drug Administration granted Travere Therapeutics full approval for FILSPARI in focal segmental glomerulosclerosis on April 13, 2026, the ...
Sales at Walmart’s U.S. stores rose just 2.6% in the latest quarter, while the retailer’s stock plunged more than 9% Thursday, its steepest one-da...
The value of retail trade in the country rose 0.6% in June from the month before to a seasonally adjusted 74.28 billion Canadian dollars, the equivale...
Revenue rose 26% to $27 million in the first half. Management expects 60–73% growth in the second half while scaling via partner trucks. The post Ei...
In the second quarter ended July 31, US comparable sales – at stores and digital channels open for at least 12 months – rose 2.6%, the smallest in...
Zim’s Q2 net income rose on higher rates and volume as it reaffirmed full-year guidance as its pending merger with Hapag-Lloyd progresses. The post ...
The Conference Board’s Leading Economic Index rose by 0.2% to 99.5, indicating that moderate growth could be coming.
Canadian developer Cadillac Mines (TSX: CADY) says new drilling at its past-producing Kerr-Addison property in Ontario could open the door to a larger...
The reserve bank’s manufacturing business outlook survey showed that the current-activity index rose to 47.4 in August from 41.4 in July.
Dressed in pink, and in some cases holding infants, supporters of Lindsay Clancy showed up outside the Massachusetts courtroom where she’s standing ...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE